Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
7
NMPA:7
Drug Approvals
Sitagliptin and Metformin Hydrochloride Sustained-Release tablets
- Product Name
- 西格列汀二甲双胍缓释片
- Approval Number
- 国药准字H20253646
- Approval Date
- Mar 18, 2025
NMPA
Sitagliptin Phosphate Tablets
- Product Name
- 磷酸西格列汀片
- Approval Number
- 国药准字H20233945
- Approval Date
- Jul 25, 2023
NMPA
Olmesartan Medoxomil and Hydrochlorothiazide Tablets
- Product Name
- 奥美沙坦酯氢氯噻嗪片
- Approval Number
- 国药准字H20233037
- Approval Date
- Jan 10, 2023
NMPA
Clinical Trials
No trials found
News
No news found